Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2024-08-19
2024-11-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The research will be conducted with a pre-test post-test single group, quasi-experimental research design.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Stimulation Therapy for Dementia
NCT05514678
Home-Based Telerehabilitation for People With Alzheimer Disease
NCT04606251
The Effect of Digital Reminiscence Therapy on People With Mild and Moderate Dementia
NCT05341271
Complementary Interventions on Patients With Dementia: Comparative and Longitudinal Research
NCT02126059
Education of Caregivers of Alzheimer's Patients
NCT06182930
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reminiscence group
Reminiscence therapies will be applied to individuals with dementia
Reminiscence therapy
Reminiscence therapies will be applied to individuals with dementia in 45-minute sessions once a week for 8 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reminiscence therapy
Reminiscence therapies will be applied to individuals with dementia in 45-minute sessions once a week for 8 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Getting a score between 13-23 for the educated (literate) and 10-23 for the uneducated (illiterate) on the mini mental state examination,
* Being 65 years of age or older,
* Being able to communicate,
* No vision or hearing problems,
* Consent to participate in the research.
Exclusion Criteria
* Having an acute illness that prevents participation in intervention sessions,
* Having serious sensory and physical limitations that prevent participation,
* Having severe neuropsychiatric symptoms (agitation, psychosis, apathy, uncontrolled delirium, etc.),
* Having a traumatic life history,
* Having recently participated in a similar program.
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Scientific and Technological Research Council of Turkey
OTHER
Amasya University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Merve çayır yılmaz, asst. prof.
Role: PRINCIPAL_INVESTIGATOR
Amasya University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Merve Çayır Yılmaz
Amasya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
amasyau-mçy-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.